A study of Dopamine uses the DRD5-ARRB2-PP2A signalling axis to block the TRAF6-mediated NFkB pathway and suppress systemic inflammation. Wu et al
Published: 28 January 2020| Version 1 | DOI: 10.17632/r68gw2wbwy.1
Contributor:
Shuo YangDescription
The raw pictures of blots and immunofluorescence data in all main and supplementary figures.
Files
Categories
Inflammation, Dopamine